Show simple item record

dc.contributor.authorGalarreta Rodríguez, Itziar ORCID
dc.contributor.authorEtxebeste-Mitxeltorena, Mikel
dc.contributor.authorMoreno, Esther
dc.contributor.authorPlano, Daniel
dc.contributor.authorSanmartín, Carmen
dc.contributor.authorMegahed, Saad
dc.contributor.authorFeliu, Neus
dc.contributor.authorParak, Wolfgang J.
dc.contributor.authorGaraio, Eneko
dc.contributor.authorGil de Muro Zabala, Izaskun ORCID
dc.contributor.authorLezama Diago, Luis María
dc.contributor.authorRuiz de Larramendi Villanueva, Idoia
dc.contributor.authorInsausti Peña, María Teresa
dc.date.accessioned2023-09-25T15:29:32Z
dc.date.available2023-09-25T15:29:32Z
dc.date.issued2023-06-30
dc.identifier.citationPharmaceuticals 16(7) : (2023) // Article ID 949es_ES
dc.identifier.issn1424-8247
dc.identifier.urihttp://hdl.handle.net/10810/62669
dc.description.abstractIn recent years, much effort has been invested into developing multifunctional drug delivery systems to overcome the drawbacks of conventional carriers. Magnetic nanoparticles are not generally used as carriers but can be functionalised with several different biomolecules and their size can be tailored to present a hyperthermia response, allowing for the design of multifunctional systems which can be active in therapies. In this work, we have designed a drug carrier nanosystem based on Fe3O4 nanoparticles with large heating power and 4-amino-2-pentylselenoquinazoline as an attached drug that exhibits oxidative properties and high selectivity against a variety of cancer malignant cells. For this propose, two samples composed of homogeneous Fe3O4 nanoparticles (NPs) with different sizes, shapes, and magnetic properties have been synthesised and characterised. The surface modification of the prepared Fe3O4 nanoparticles has been developed using copolymers composed of poly(ethylene-alt-maleic anhydride), dodecylamine, polyethylene glycol and the drug 4-amino-2-pentylselenoquinazoline. The obtained nanosystems were properly characterised. Their in vitro efficacy in colon cancer cells and as magnetic hyperthermia inductors was analysed, thereby leaving the door open for their potential application as multimodal agents.es_ES
dc.description.sponsorshipThis work was supported by institutional funding from the Ministry of Economy and Competitiveness and Basque Government under projects PID2019-106845RB-100 (AEI/FEDER, UE) and GIC-IT-1546-22. WJP was supported by the Cluster of Excellence Advanced Imaging of Matter of the Deursche Forschungsgemeinschaft (DFG)-EXC 2056—project ID 390715994. SM was financed by a PhD fellowship from the German Academic Exchange Service (DAAD). NF was supported by Fraunhofer Attract.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/MINECO/PID2019-106845RB-100es_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectmagnetic nanoparticleses_ES
dc.subjectdrug carrierses_ES
dc.subjectmagnetic hyperthermia inductores_ES
dc.titlePreparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe3O4 Nanoparticles as Multimodal Drug Carrier and Magnetic Hyperthermia Inductores_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.date.updated2023-07-28T12:21:45Z
dc.rights.holder© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).es_ES
dc.relation.publisherversionhttps://www.mdpi.com/1424-8247/16/7/949es_ES
dc.identifier.doi10.3390/ph16070949
dc.departamentoesQuímica Orgánica e Inorgánica
dc.departamentoeuKimika Organikoa eta Ez-Organikoa


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Except where otherwise noted, this item's license is described as © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).